Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

Climate factors like UV index and rain can affect alopecia areata flares in children, especially those with allergies.

Alopecia areata mainly affects young people, often showing as patchy hair loss on the scalp.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Winter-onset alopecia areata patients are more likely to regrow hair within a year compared to spring-onset patients.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Alopecia areata negatively affects self-esteem, relationships, and academics in young people.

Erianin may effectively treat alopecia areata by targeting the immune system.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

The guidelines offer updated treatment recommendations for alopecia areata in Korea using topical and device-based methods.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Severe pediatric alopecia areata worsens quality of life for patients and families.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Current treatments for Alopecia Areata are unsatisfactory and need improvement.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

The criteria help doctors diagnose and treat alopecia areata more effectively.

Corticosteroids may not effectively control oxidative stress in alopecia areata, possibly leading to relapses.

Low vitamin D levels may worsen or cause alopecia areata.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Distinct miRNA signatures could help diagnose and treat severe Alopecia Areata.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Children with alopecia areata often have vitiligo, allergic asthma, ADHD, and low vitamin B12 and ferritin levels.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.